Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-18-004408
Filing Date
2018-04-13
Accepted
2018-04-13 13:43:37
Documents
64
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10kt2017_americanbrivision.htm 10-KT 1254740
2 CERTIFICATION f10k2017n2ex31-1_american.htm EX-31.1 9607
3 CERTIFICATION f10k2017n2ex31-2_american.htm EX-31.2 9744
4 CERTIFICATION f10k2017n2ex32-1_american.htm EX-32.1 3642
5 CERTIFICATION f10k2017n2ex32-2_american.htm EX-32.2 3952
6 GRAPHIC image_001.jpg GRAPHIC 1661
7 GRAPHIC image_002.jpg GRAPHIC 2758
  Complete submission text file 0001213900-18-004408.txt   4630667

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE abvc-20171231.xml EX-101.INS 803663
9 XBRL SCHEMA FILE abvc-20171231.xsd EX-101.SCH 42791
10 XBRL CALCULATION FILE abvc-20171231_cal.xml EX-101.CAL 48437
11 XBRL DEFINITION FILE abvc-20171231_def.xml EX-101.DEF 128369
12 XBRL LABEL FILE abvc-20171231_lab.xml EX-101.LAB 247059
13 XBRL PRESENTATION FILE abvc-20171231_pre.xml EX-101.PRE 226213
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 333-91436 | Film No.: 18753876
SIC: 2834 Pharmaceutical Preparations